FDA.reportPublic FDA data

ETHYLCELLULOSE (20 MPA.S)

Substance profile for UNII BJG0S321QY, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
BJG0S321QY
Preferred term
ETHYLCELLULOSE (20 MPA.S)
Registry number
9004-57-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1313697
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1313697mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1313697
FDA Substance Registration SystemBJG0S321QYprecision.fda.gov/uniisearch/srs/unii/BJG0S321QY

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
KLOR-CON ® M (Potassium Chloride Extended-release Tablets, USP) 10 mEq, 15 mEq and 20 mEq MICRO-DISPERSIBLE TECHNOLOGY ® Rx only1
Potassium Chloride Extended-release Tablets, USP Microencapsulated3
Diltiazem Hydrochloride Extended-Release Capsules, USP [Once-a-Day Dosage]1
Potassium Chloride Extended-release Tablets, USP Microencapsulated1
ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]49
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [MALLINCKRODT, INC.]11
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED]10
POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [CARDINAL HEALTH]7
DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]4
POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [SANDOZ INC]4
CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.]3
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]3
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.]3
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]2
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [UNIT DOSE SERVICES]2
KLOR-CON M10 (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE KLOR-CON M20 (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH]2
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING]2
CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [NOSTRUM LABORATORIES, INC.]1
CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]1
DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ST MARYS MEDICAL PARK PHARMACY]1
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH]1
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [MCKESSON CONTRACT PACKAGING]1
KLOR-CON M (POTASSIUM CHLORIDE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [KAISER FOUNDATION HOSPITALS]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII BJG0S321QY page 1 of 1 · 6 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
ETHYLCELLULOSE (20 MPA.S)BJG0S321QY9004573CAPSULEORAL32.2 mg
ETHYLCELLULOSE (20 MPA.S)BJG0S321QY9004573CAPSULE, COATED, EXTENDED RELEASEORAL36 mg
ETHYLCELLULOSE (20 MPA.S)BJG0S321QY9004573CAPSULE, EXTENDED RELEASEORAL882 mg
ETHYLCELLULOSE (20 MPA.S)BJG0S321QY9004573GRANULEORAL0.01 mg
ETHYLCELLULOSE (20 MPA.S)BJG0S321QY9004573SUSPENSION, EXTENDED RELEASEORAL1538 mg
ETHYLCELLULOSE (20 MPA.S)BJG0S321QY9004573TABLET, EXTENDED RELEASEORAL1547 mg